BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 20457724)

  • 1. Local excision following pre-operative chemoradiotherapy-induced downstaging for selected cT3 distal rectal cancer.
    Yeo SG; Kim DY; Kim TH; Kim SY; Chang HJ; Park JW; Choi HS; Oh JH
    Jpn J Clin Oncol; 2010 Aug; 40(8):754-60. PubMed ID: 20457724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
    Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
    Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ
    Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of long-term follow-up for transanal excision for rectal cancer.
    Gonzalez QH; Heslin MJ; Shore G; Vickers SM; Urist MM; Bland KI
    Am Surg; 2003 Aug; 69(8):675-8; discussion 678. PubMed ID: 12953825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
    Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
    Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transanal local wide excision for rectal adenocarcinoma.
    Chen CC; Leu SY; Liu MC; Jian JJ; Chen CM
    Hepatogastroenterology; 2005; 52(62):460-3. PubMed ID: 15816457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence after transanal excision of T1 rectal cancer: should we be concerned?
    Madbouly KM; Remzi FH; Erkek BA; Senagore AJ; Baeslach CM; Khandwala F; Fazio VW; Lavery IC
    Dis Colon Rectum; 2005 Apr; 48(4):711-9; discussion 719-21. PubMed ID: 15768186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
    Thomschke D; Kyau-Ummen B; Halbfass HJ
    Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical salvage of recurrent rectal cancer after transanal excision.
    Weiser MR; Landmann RG; Wong WD; Shia J; Guillem JG; Temple LK; Minsky BD; Cohen AM; Paty PB
    Dis Colon Rectum; 2005 Jun; 48(6):1169-75. PubMed ID: 15793645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
    Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy.
    Valentini V; Coco C; Minsky BD; Gambacorta MA; Cosimelli M; Bellavita R; Morganti AG; La Torre G; Trodella L; Genovesi D; Portaluri M; Maurizi-Enrici R; Barbera F; Maranzano E; Lupattelli M
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):403-12. PubMed ID: 17919844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
    J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimedia article. Laparoscopic ultralow anterior resection with colonic J-pouch-anal anastomosis.
    Selvindos PB; Ho YH
    Dis Colon Rectum; 2008 Nov; 51(11):1710-1. PubMed ID: 18679748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted.
    Guillem JG; Díaz-González JA; Minsky BD; Valentini V; Jeong SY; Rodriguez-Bigas MA; Coco C; Leon R; Hernandez-Lizoain JL; Aristu JJ; Riedel ER; Nitti D; Wong WD; Pucciarelli S
    J Clin Oncol; 2008 Jan; 26(3):368-73. PubMed ID: 18202411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downstaging after chemoradiotherapy for locally advanced rectal cancer: is there more (tumor) than meets the eye?
    Mignanelli ED; de Campos-Lobato LF; Stocchi L; Lavery IC; Dietz DW
    Dis Colon Rectum; 2010 Mar; 53(3):251-6. PubMed ID: 20173469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution.
    Perez RO; Habr-Gama A; Lynn PB; São Julião GP; Bianchi R; Proscurshim I; Gama-Rodrigues J
    Dis Colon Rectum; 2013 Jan; 56(1):6-13. PubMed ID: 23222274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of resection of stage IV rectal cancer with mesorectal excision.
    Law WL; Chu KW
    J Surg Oncol; 2006 Jun; 93(7):523-8. PubMed ID: 16705728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: An analysis of outcomes in a randomized trial.
    Bujko K; Michalski W; Kepka L; Nowacki MP; Nasierowska-Guttmejer A; Tokar P; Dymecki D; Pawlak M; Lesniak T; Richter P; Wojnar A; Chmielik E;
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):369-77. PubMed ID: 17118570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
    Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.